We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.8B Turnover 33.11%
1-Year Est. Return 26.98%
 

Squarepoint runs funds that use computer models to trade many kinds of assets around the world. It began as nQuant, a trading unit set up inside Lehman Brothers in 2000 by its founders, Olivier Durantel and Gregoire Schneider. Barclays took over nQuant in 2008, and in December 2014 it was spun off as an independent firm and renamed Squarepoint. In 2022 Squarepoint formed STG, a separate trading group that shares much of its infrastructure but has its own investment staff, and in 2021 it partnered with Arini Capital, a European hedge fund.

This Fund
S&P 500
This Quarter Est. Return
+4.02%
1 Year Est. Return
+26.98%
3 Year Est. Return
+88.41%
5 Year Est. Return
+62.11%
10 Year Est. Return
+188.73%
AUM
$7.55B
AUM Growth
+$1.25B
Cap. Flow
+$1.17B
Cap. Flow %
15.56%
Top 10 Hldgs %
9.43%
Holding
2,269
New
635
Increased
628
Reduced
448
Closed
556
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0 years
Top 20 Avg Time Held Equity + Options
0.1 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0 years
Top 20 Avg Time Held Equity only
0.1 years

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17%
2 Financials 13.53%
3 Healthcare 13.33%
4 Technology 13.18%
5 Industrials 11.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CTIC
1676
DELISTED
CTI BioPharma
CTIC
$65K ﹤0.01%
+13,102
New +$57.3K
2018 Q2
0 quarters
LTS
1677
DELISTED
Ladenburg Thalmann Financial Services
LTS
$64K ﹤0.01%
18,800
+6,000
+47% +$21K
2017 Q4
2 quarters
AQMS icon
1678
Aqua Metals
AQMS
$3.6M
$62K ﹤0.01%
+108
New +$66.4K
2018 Q2
0 quarters
HBIO icon
1679
Harvard Bioscience
HBIO
$41.7M
$61K ﹤0.01%
+1,131
New +$57.9K
2018 Q2
0 quarters
ACET icon
1680
DELISTED
Aceto Corp
ACET
$61K ﹤0.01%
+18,178
New +$71.4K
2018 Q2
0 quarters
TLGT
1681
DELISTED
Teligent
TLGT
$60K ﹤0.01%
+1,725
New +$54.3K
2018 Q2
0 quarters
MACK icon
1682
DELISTED
Merrimack Pharmaceuticals
MACK
$60K ﹤0.01%
+15,605
New +$104K
2018 Q2
0 quarters
AVID
1683
DELISTED
Avid Technology
AVID
$59K ﹤0.01%
+11,301
New +$55.2K
2018 Q2
0 quarters
MVIS icon
1684
Microvision
MVIS
$32.9M
$58K ﹤0.01%
+3,473
New +$69K
2018 Q2
0 quarters
KA icon
1685
DELISTED
Kineta
KA
$58K ﹤0.01%
+150
New +$93.9K
2018 Q2
0 quarters
SHLD icon
1686
DELISTED
Sears Holdings
SHLD
$58K ﹤0.01%
+24,602
New +$72K
2018 Q2
0 quarters
ENT
1687
DELISTED
Global Eagle Entertainment
ENT
$56K ﹤0.01%
+888
New +$38.8K
2018 Q2
0 quarters
NBRV
1688
DELISTED
Nabriva Therapeutics
NBRV
$53K ﹤0.01%
+61
New +$69.9K
2018 Q2
0 quarters
FRED
1689
DELISTED
Fred's
FRED
$53K ﹤0.01%
+23,251
New +$50.6K
2018 Q2
0 quarters
ADMA icon
1690
ADMA Biologics
ADMA
$3.03B
$50K ﹤0.01%
+11,046
New +$55.1K
2018 Q2
0 quarters
PXLW icon
1691
Pixelworks
PXLW
$37.1M
$47K ﹤0.01%
+1,088
New +$53.4K
2018 Q2
0 quarters
VIVS icon
1692
VivoSim Labs
VIVS
$2.46M
$47K ﹤0.01%
139
+52
+60% +$17.1K
2017 Q4
2 quarters
HSTO
1693
DELISTED
Histogen
HSTO
$46K ﹤0.01%
+54
New +$44.8K
2018 Q2
0 quarters
IMDZ
1694
DELISTED
Immune Design
IMDZ
$46K ﹤0.01%
+10,111
New +$40.3K
2018 Q2
0 quarters
MGNI icon
1695
Magnite
MGNI
$4.08B
$44K ﹤0.01%
+15,290
New +$36.4K
2018 Q2
0 quarters
RRTS
1696
DELISTED
Roadrunner Transportation Systems
RRTS
$44K ﹤0.01%
837
+347
+71% +$19.3K
2017 Q4
2 quarters
HDSN icon
1697
Hudson Technologies
HDSN
$173M
$43K ﹤0.01%
+21,366
New +$69.3K
2018 Q2
0 quarters
VBIV icon
1698
DELISTED
VBI Vaccines
VBIV
$43K ﹤0.01%
+516
New +$49.8K
2018 Q2
0 quarters
TRVN icon
1699
DELISTED
Trevena
TRVN
$43K ﹤0.01%
+47
New +$51.8K
2018 Q2
0 quarters
MR
1700
DELISTED
Montage Resources
MR
$42K ﹤0.01%
+1,742
New +$38.9K
2018 Q2
0 quarters

Similar funds

Squarepoint's Q2 2018 Portfolio in Review

As of Q2 2018, Squarepoint held 2,269 positions worth $7.55B, up 20% from $6.3B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Squarepoint deployed $1.17B of net new capital in Q2 2018, opening 635 new positions and adding to 628 existing holdings. Its largest new stake was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares MSCI India ETF, an estimated $47.3M trimmed.

  • Squarepoint's largest Q2 2018 buy was Vanguard FTSE Emerging Markets ETF: 1,889,716 shares worth $79.7M.
  • Squarepoint added most to iShares MSCI Taiwan ETF in Q2 2018, an estimated $102M increase.
  • Squarepoint's biggest Q2 2018 reduction was iShares MSCI India ETF, cutting an estimated $47.3M.
  • Squarepoint fully exited iShares MSCI Brazil ETF in Q2 2018, selling an estimated $119M.
  • Squarepoint's ten largest holdings make up 9.4% of its $7.55B portfolio in Q2 2018.
  • Squarepoint opened 635 new positions and closed 556 in Q2 2018.
  • Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.55B.

Based on Squarepoint's 13F filing for Q2 2018, filed 14 Aug 2018.